The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the \u20182022 INTERCOVID Study\u2019 conducted in 41 hospitals across 18 countries.
A consortium led by Matthew Wood, Professor of Neuroscience in the Department of Paediatrics and Director of the Oxford-Harrington Rare Disease Centre, has been awarded \u00a38m of funding from UKRI, LifeArc and the Nucleic Acid Therapy Accelerator (NATA) via the Nucleic Acid Therapies (NAT) Delivery Research Challenge.
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 \u2013 the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.
Professor Knight's research focuses on the care and prevention of severe complications of pregnancy and early life and addressing disparities in outcomes for women and babies from different population groups.
A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
Photographer in Residence at Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, Pearl Gan's photograph is featured as one of the winners in The Lancet's Highlights 2022. Highlights is The Lancet's annual photography competition and this year's competition focussed on health-related topics.
New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient\u2019s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
More than 40,000 doses of Oxford\u2019s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
Every day, thousands of parents and grandparents are diagnosed with serious health conditions such as cancer, lung or heart disease. They are then faced with the unenviable task of sharing this information with the children they love.
Nearly one in 10 young people are experiencing both persistent physical pain and suicidal feelings, according to a new paper from researchers from the University of Oxford, Cambridge, Oslo (Norway), King\u2019s College London, and the Parc Sanitari Sant Joan de Deu (Spain).
A study published today in 'Family Practice', led by researchers at the University of Oxford, finds that when doctors tell patients living with obesity to lose weight, the guidance they give is generally vague, superficial, and commonly not supported by scientific evidence.
Part of this new funding will help the Dementias Platform UK team work with the MND community to translate scientific discoveries into real-world treatments.
Alexandra Preston, a doctoral student from MRC Human Immunology Unit (MRC Weatherall Institute of Molecular Medicine), delivered a plenary talk on 11th December at the ASH Meeting and Exposition in New Orleans, Louisiana.
In his talk, Demis mentioned how they were able to solve the protein folding problem with AlphaFold. For 50 years, people have been working on protein folding, a problem first articulated by Nobel Prize winner Christian Anfinsen.
IBD-associated colorectal cancers were found to occur in younger patients and have worse outcomes. Researchers call for urgent improvement of early detection methods to provide more risk-based and personalised care.
A 35-page full-colour report was sent out to hundreds of donors as a thank you for their important contributions, and to show them the difference they helped to make during the pandemic.
In this long read published to coincide with International AIDS Day, we explore how an international collaboration \u2013 of which the University of Oxford is a key partner \u2013 has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.
The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.
![\"Vaccines](\"https://www.medsci.ox.ac.uk/news/vaccination-shown-to-protect-against-pregnancy-complications-from-covid-19-omicron-variant/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n